Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lupus Erythematosus, Systemic × Exercise × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 46 Breast Neoplasms 27 Neoplasms 17 Colorectal Neoplasms 7 Prostatic Neoplasms 6 Obesity 6 Lymphedema 5 Colonic Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Ovarian Neoplasms 4 Multiple Myeloma 4 Lymphoma, Follicular 4 Hematologic Neoplasms 4 Fatigue 4 Endometrial Neoplasms 4 Brain Neoplasms 4 Sarcopenia 3 Polycystic Ovary Syndrome 3 Pancreatic Neoplasms 3 Lymphoma 3 Esophageal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Skin Neoplasms 2 Recurrence 2 Peripheral Nervous System Diseases 2 Overweight 2 Neoplasm Metastasis 2 Melanoma 2 Medulloblastoma 2 Malnutrition 2

Interventions

sotrovimab 1 ciclesonide 1 anifrolumab 1 Standard of Care 1 Specimen Handling 1 Practice Guidelines as Topic 1 Nivolumab 1 Niclosamide 1 Methods 1 Interviews as Topic 1 Immune Checkpoint Inhibitors 1 High-Intensity Interval Training 1 Exercise 1 Educational Status 1 Early Intervention, Educational 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05478018 2025-09-09

LUPEX

Rigshospitalet, Denmark

Phase NA Completed

Lupus Erythematosus, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡